Tradestie Institutional Equity Comparison Engine

GEHC vs SYK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GEHC Overall Edge

GEHC Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to GE HealthCare Technologies Inc. Common Stock (GEHC) driven by superior Valuation, Momentum & Technical while SYK counters with relative strength in Growth & Margin. Fundamentally, GEHC trades at 15.1x Forward P/E with 13.8% operating margin (+7.2% YoY revenue) versus SYK at 19.0x Forward P/E and 24.0% operating margin (+7.6% YoY). In options structure, GEHC sits in SURGE (6th %ile IV; Dealer Gamma Walls on Pro) against SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GEHC
GEHC 15.1x vs SYK 19.0x Fwd P/E
Growth & Margin Winner SYK
Op Margin 13.8% vs 24.0% ยท YoY +7.2% vs +7.6%
Momentum & Technical Winner GEHC
1Y +12.5% vs -16.8% ยท 52W Pos 79% vs 36%
Options & Structure Winner Tie
SURGE (6th %ile IV) vs SURGE (5th %ile IV)
GEHC NASDAQ
GE HealthCare Technologies Inc. Common Stock
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$83.19
+0.2% 1D
Market Cap $37.0B
1M Return +19.57%
1Y Return +12.46%
Forward P/E 15.1x
Unified AI Score
36.0 / 100 SELL
Tech 20.0 Fund 32.0 Flow 58.0 Mom 40.0
SYK NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap $118.9B
1M Return +5.47%
1Y Return -16.77%
Forward P/E 19.0x
Unified AI Score
46.5 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 58.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GEHC +12.46% SYK -16.77% Spread: +29.23 pp (GEHC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period GEHC Revenue SYK Revenue GEHC Op. Margin SYK Op. Margin Margin Edge
FY2018 N/A $13.6B N/A 18.7% SYK
FY2019 N/A $14.9B N/A 18.2% SYK
FY2020 N/A $14.3B N/A 15.5% SYK
FY2021 $17.6B $17.1B 15.9% 15.1% GEHC
FY2022 $18.3B $18.4B 13.8% 15.4% SYK
FY2023 $19.6B $20.5B 12.5% 19.0% SYK
FY2024 $19.7B $22.6B 13.3% 16.3% SYK
FY2025 $20.6B $25.1B 13.4% 19.5% SYK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GEHC (5) vs SYK (5)
Institutional Metric GEHC SYK Criterion Row Winner
Market Capitalization Scale $37.0B $118.9B Larger Scale SYK
Trailing P/E Ratio Valuation 17.3x 33.3x Lower Multiple GEHC
Forward P/E Ratio Valuation 15.1x 19.0x Lower Multiple GEHC
Revenue Growth (YoY) Growth +7.2% +7.6% Higher Growth SYK
Operating Margin (TTM) Profitability 13.8% 24.0% Higher Margin SYK
Net Profit Margin Profitability 10.0% 13.8% Higher Margin SYK
Return on Equity (ROE) Capital Efficiency 20.0% 16.0% Higher ROE GEHC
52-Week Range Position Momentum 79% ($59โ€“$90) 36% ($267โ€“$389) Stronger Trend GEHC
Beta / 30D Volatility Risk Regime 0.53ฮฒ ยท 39% Vol 0.22ฮฒ ยท 50% Vol Lower Realized Risk GEHC
Unified Institutional Score Composite Signal 36.0 / 100 (SELL) 46.5 / 100 (HOLD) Higher Composite SYK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GEHC vs SYK Buy Guide
GEHC SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live GEHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SYK SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SYK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GEHC nor SYK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.